Cargando…

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis

Treatment of multidrug-resistant tuberculosis (MDR-TB) is extremely challenging due to the virulence of the etiologic strains of Mycobacterium tuberculosis (M. tb), the aberrant host immune responses and the diminishing treatment options with TB drugs. New treatment regimens incorporating therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zumla, Alimuddin, Rao, Martin, Dodoo, Ernest, Maeurer, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908783/ https://www.ncbi.nlm.nih.gov/pubmed/27301245 http://dx.doi.org/10.1186/s12916-016-0635-1

Ejemplares similares

Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies
por: Rao, Martin, et al.
Publicado: (2019)

Vitamin D as Adjunctive Host-Directed Therapy in Tuberculosis: A Systematic Review
por: Wallis, Robert S., et al.
Publicado: (2016)

B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis
por: Rao, Martin, et al.
Publicado: (2015)

Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review
por: Kroesen, Vera M., et al.
Publicado: (2017)

Reducing mortality from 2019-nCoV: host-directed therapies should be an option
por: Zumla, Alimuddin, et al.
Publicado: (2020)

Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity
por: Rao Muvva, Jagadeeswara, et al.
Publicado: (2021)

Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections
por: Zumla, Alimuddin, et al.
Publicado: (2015)

Use of the Xpert® MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia
por: Bates, Matthew, et al.
Publicado: (2013)

Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
por: Ramalho, Renata, et al.
Publicado: (2020)

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Delamanid expanded access novel treatment of drug resistant tuberculosis
por: Rustomjee, Roxana, et al.
Publicado: (2015)

A Broad Profile of Co-Dominant Epitopes Shapes the Peripheral Mycobacterium tuberculosis Specific CD8+ T-Cell Immune Response in South African Patients with Active Tuberculosis
por: Axelsson-Robertson, Rebecca, et al.
Publicado: (2013)

Adjunctive therapies and immunomodulatory agents in the management of severe influenza
por: Hui, David S., et al.
Publicado: (2013)

Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis
por: Singh, Dhiraj Kumar, et al.
Publicado: (2021)

Toning down the 2019-nCoV media hype—and restoring hope
por: Ippolito, Giuseppe, et al.
Publicado: (2020)

T-Cell Therapy: Options for Infectious Diseases
por: Parida, Shreemanta K., et al.
Publicado: (2015)

CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
por: Meng, Qingda, et al.
Publicado: (2018)

Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.
por: Ntoumi, Francine, et al.
Publicado: (2022)

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants
por: Zumla, Alimuddin, et al.
Publicado: (2018)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies
por: Lérias, Joana R., et al.
Publicado: (2020)

Tuberculosis — An Epidemic of Injustice
por: Grange, John, et al.
Publicado: (1997)

Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities
por: Lérias, Joana R., et al.
Publicado: (2020)

The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis
por: Shen, Hong, et al.
Publicado: (2015)

Are There Sex-Specific Differences in Response to Adjunctive Host-Directed Therapies for Tuberculosis?
por: Dutta, Noton K., et al.
Publicado: (2020)

The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis
por: Nienaber, Arista, et al.
Publicado: (2021)

Rapid diagnostics urgently needed for killer infections
por: Zumla, Alimuddin, et al.
Publicado: (2013)

Pattern recognition and cellular immune responses to novel Mycobacterium tuberculosis-antigens in individuals from Belarus
por: Ahmed, Raija K, et al.
Publicado: (2012)

Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection — Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base
por: Nachega, Jean B., et al.
Publicado: (2021)

Childhood Tuberculosis and Infection with the Human Immunodeficiency Virus
por: Chintu, Chifumbe, et al.
Publicado: (1995)

The effects of anti-inflammatory agents as host-directed adjunct treatment of tuberculosis in humans: a systematic review and meta-analysis
por: Hayford, Frank Ekow Atta, et al.
Publicado: (2020)

Latent tuberculosis and the use of immunomodulatory agents
por: Aguiar, Fábio Silva, et al.
Publicado: (2019)

Taking forward the World TB Day 2016 theme ‘Unite to End Tuberculosis’ for the WHO Africa Region
por: Ntoumi, Francine, et al.
Publicado: (2016)

The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB
por: Chakaya, Jeremiah, et al.
Publicado: (2022)

The concept of rapid rescue radiosurgery in the acute management of critically located brain metastases: A retrospective short-term outcome analysis
por: Sinclair, Georges, et al.
Publicado: (2018)

Adaptive hypofractionated gamma knife radiosurgery in the acute management of brainstem metastases
por: Sinclair, Georges, et al.
Publicado: (2019)

The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review
por: Lee, Chiyun, et al.
Publicado: (2021)

Middle East Respiratory Syndrome - need for increased vigilance and watchful surveillance for MERS-CoV in sub-Saharan Africa
por: Zumla, Alimuddin, et al.
Publicado: (2015)

Ozone adjunct treatment in facing multidrug‐resistant bacteria?
por: Chirumbolo, Salvatore, et al.
Publicado: (2023)

Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options
por: Zumla, Alimuddin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6vv1ki2bcufiip97noqgpkbqed